Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on PK of Y-4 Tablets in Healthy Subjects
NCT07013773Phase 1Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- May 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Y-4 in postherpetic neuralgia (PHN) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoints: Adverse Events, Incidence of Abnormal Laboratory Tests and 5 more. Started May 2025; status: recruiting.
02
Drugs
Y-4
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT07013773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07013773.